| Trial registration number
|
IRCT20210113050024N3 |
Full text link
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/58715
|
First author
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dr. Shaghayegh Haghjoi Javanmard
|
Contact
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
babaktamizifar@gmail.com
|
Registration date
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-09-16
|
Recruitment status
Last imported at : March 20, 2022, 9:39 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
nonRCT
|
Allocation
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Non-randomized
|
Design
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Single group assignment
|
Masking
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Open label
|
Center
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Prevention
|
Inclusion criteria
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
The IBD patients
Willing to cooperate in completing the questionnaire and secondary follow-up
Be over 18 years old.
|
Exclusion criteria
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patient non-cooperation
The patient is in a state of recurrence and has symptoms of bleeding and fever during this period
|
Number of arms
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
1
|
Funding
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Esfahan University of Medical Sciences
|
Inclusion age min
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Healthy volunteers
|
Severity scale
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
N/A
|
Total sample size
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
30
|
primary outcome
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Fecal chlorprotectin levels
Illness severity
|
Notes
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 2
|
Arms
Last imported at : Sept. 16, 2021, 1 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "1", "treatment_id": 1911, "treatment_name": "Covid-19 vaccine", "treatment_type": "Other covid vaccine", "pharmacological_treatment": "Vaccine"}]
|